Skip to main content

Table 3 Comparison of AQLQ test results in patients with asthma before and after the intervention

From: Immunomodulatory effects of probiotic supplementation in patients with asthma: a randomized, double-blind, placebo-controlled trial

Variables

Probiotic group (n = 17)

Placebo group (n = 18)

Cohen’s d (95% CI)

p

ACT

 Baseline

15.41 ± 4.5

14.67 ± 2.3

0.06 (−0.61 to 0.72)

0.41t

 2nd consultation

18.65 ± 4.2

16.22 ± 4.79

0.53 (−0.15 to 1.20)

0.13t

 Cohen’s d (95% CI)

−0.73 (−1.42 to −0.03)

−0.41 (−1.08 to 0.26)

  

 p

0.0001tp

0.051tp

  

AQLQ

 Baseline

2.4 ± 0.96

2.63 ± 0.83

−0.06 (−0.73 to 0.63)

0.50t

 2nd consultation

3.6 ± 0.98

2.87 ± 0.80

0.79 (0.10 to 1.48)

0.01t

 Cohen’s d (95% CI)

−1.21 (−1.94 to −0.48)

−0.29 (−0.94 to 0.37)

  

p

0.0001tp

0.06tp

  
  1. T Student’s t and W the Wilcoxon Mann-Whitney tests for independent samples and Tp Student’s t and Wp the Wilcoxon tests for paired samples.
  2. FEV1 forced expiratory volume in one second, FVC orced vital capacity,